High Response Rate With First Targeted Drug for Bladder Cancer High Response Rate With First Targeted Drug for Bladder Cancer

The novel targeted drug is welcomed by experts as an option in the second-line treatment of patients with metastatic bladder cancers and FGFR genetic alterations.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news